Therapy with lithium salts in child and adolescent psychiatry - Clinical efficacy and practical recommendations;Therapie mit lithiumsalzen in der kinder- und jugendpsychiatrie - Klinische wirksamkeit und praktische empfehlungen

Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie

Volumn 34, Issue 3, 2006, Pages 181-189

  Gerlach, Manfred ^a,d   Baving, Lioba ^b,d   Fegert, Joerg ^c,d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d Psychosomatik und Psychotherapie ^*  (Germany)

Author keywords

Bipolar disorder; Impulsive disorder; Mania; Mood stabilizer; Pharmacotherapy

Indexed keywords

ANTIBIOTIC AGENT; CARBAMAZEPINE; HYPNOREX RETARD; LEKOMINERASE; LITHIUM ACETATE; LITHIUM APOGEPHA; LITHIUM ASPARTAT; LITHIUM CARBONATE; LITHIUM SALT; LITHIUM SULFATE; MOOD STABILIZER; NEUROLEPTIC AGENT; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; THIAZIDE DIURETIC AGENT;

AGGRESSIVENESS; BIPOLAR DISORDER; CHILD PSYCHIATRY; CLINICAL EFFECTIVENESS; CONSENSUS DEVELOPMENT; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; EVIDENCE BASED PRACTICE; HUMAN; IMPULSIVENESS; KIDNEY INJURY; MANIA; NEUROLEPTIC MALIGNANT SYNDROME; RECURRENT DISEASE; REVIEW; THERAPY EFFECT; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; AGGRESSION; ANTIMANIC AGENTS; BIPOLAR DISORDER; CHILD; EVIDENCE-BASED MEDICINE; HUMANS; IMPULSE CONTROL DISORDERS; LITHIUM COMPOUNDS; RANDOMIZED CONTROLLED TRIALS;

EID: 33745039283     PISSN: 14224917     EISSN: None     Source Type: Journal    
DOI: 10.1024/1422-4917.34.3.181     Document Type: Review

References (18)

1. Campbell, M., Small, A. M., Wayne, H. G., Jennings, S. J., Perry, R., Bennett, W.G. & Anderson, L. (1984). Behavioral efficacy of haloperidol and lithium carbonate. Archives of General Psychiatry, 41, 650-656.
2. Campbell, M., Silva, R. R., Kafantaris, V., Lacascio, J. J., Gonzalez, N. M., Lee, D. & Lynch, N. S. (1991). Predictors of side effects associated with lithium administration in children. Psychopharmacology Bulletin, 27, 373-380.
3. Campbell, M., Adams, P. B., Small, A. M., Kafantaris, V., Silva, R. R., Shel, J., Perry, R. & Overall, J. E. (1995). Lithium in hospitalized aggressive children with conduct disorders: A double-blind- and placebo controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 445-453.
4. Davanzo, P., Gunderson, B., Belin, T., Mintz, J., Pataki, C., Ott, D., Emley-Akanno, C., Montazeri, N., Oppenheimer, J. & Strober, M. (2003). Mood stabilizers in hospitalised children with bipolar disorder: a retrospective review. Psychiatry and Clinical Neuroscience, 57, 504-510.
5. Deutsche Gesellschaft für Kinder- und Jugendpsychiatrie und Psychotherapie, Berufsverband der Ärzte für Kinder- und Jugendpsychiatrie und Psychotherapie in Deutschland e. V., Bundesarbeitsgemeinschaft der leitenden Klinikärzte für Kinder- und Jugendpsychiatrie und Psychotherapie e. V. (2003). Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter. Köln: Deutscher Ärzte Verlag.
6. Geller, B., Cooper, T. B., Sun, K., Zimerman, B., Frazier, J., Williams, M. & Heath, J. (1998). Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 171-178.
7. Göthert, M., Bönisch, H., Schlicker, E. & Helmchen, H. (2001). Psychopharmaka. Pharmakotherapie psychischer Störungen. In: H. Forth, D. Henschler, W. Rummel, U. Förstermann & K. Starke K. Allgemeine und spezielle Pharmakologie und Toxikologie (8., völlig überarbeitete Auflage; pp. 335-374). München: Urban & Fischer.
8. Kaschka, W. P. (2002). Lithium. Experimentelle und klinische Pharmakologie. In: P. Riederer, G. Laux and W. Pöldinger. Neuro-Psychopharmaka. Ein Therapie-Handbuch (Band 3, Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer, 2. Auflage, pp. 792-803). Wien: Springer.
9. Kowatch, R. A., Fristad, M., Birmaher, B., Wagner, K. D., Findling, R. L. & Hellander, M. & The Child Psychiatric Work-group on Bipolar Disorder (2005). Treatment guidelines for children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 213-235.
10. Kowatch, R. A., Suppes, T., Carmody, T. J., Bucci, J. P., Hume, J. H., Kromelis, M., Emslie, G. J., Weinberg, W. A. & Rush, A. J. (2000). Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 713-720.
11. Lenox, R. H. & Hahn, C. G. (2000). Overview of the mechanism of action of lithium in the brain: fifty-year update. Journal of Clinical Psychiatry, 61 (Suppl. 9), 5-15.
12. Malone, R. P., Delaney, M. A., Luebbert, J. F., Cater, J. & Campbell, M. (2000). A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Archives of General Psychiatry, 57, 649-654.
13. Müller, W. E. & Möller, H. J. (2002). Stimmungsstabilisierer. In: P. Riederer, G. Laux & W. Pöldinger W. Neuro-Psychopharmaka. Ein Therapie-Handbuch (Band 3: Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer, 2. Auflage, pp. 97-98). Wien: Springer.
14. Ryan, N. D., Bhatara, V. S. & Perel, J. M. (1999). Mood stabilizers in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 529-536.
15. th edition). Washington: American Psychiatric Publishing.
16. Strober, M., Morrell, W., Lampert, C. & Burroughs, J. (1990). Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study. American Journal of Psychiatry, 147, 457-461.
17. Volz, H. P. & Sauer, H. (1997). Behandlung der akuten Manie mit Lithium und anderen Pharmaka. In: B. Müller-Oerlinghausen, W. Kreil & A. Berghöfer. Die Lithiumtherapie (2. Auflage, pp. 163-177). Berlin: Springer.
18. Warnke, A. & Gerlach, M. (2004). Stimmungsstabilisierer/ Phasenprophylaktika. In: M. Gerlach, A. Warnke & Ch. Wewetzer. Neuro-Psychopharmaka im Kindes- und Jugendalter: Grundlagen und Therapie (pp. 191-198). Wien: Springer.